Prolonged Lenalidomide Therapy Does Not Impact Autologous Peripheral Blood Stem Cell Mobilization and Collection in Multiple Myeloma Patients: A Single-Center Retrospective Analysis-Reference-Cited by-同舟云学术

Prolonged Lenalidomide Therapy Does Not Impact Autologous Peripheral Blood Stem Cell Mobilization and Collection in Multiple Myeloma Patients: A Single-Center Retrospective Analysis

Published:2021-08 Issue:8 Volume:27 Page:661.e1-661.e6
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Cowan Andrew J.,Stevenson Philip A.,Green Damian J.,Tuazon Sherilyn,Libby Edward N.,Kwok Mary,Lee Sarah,Coffey David G.,Gopal Ajay K.,Holmberg Leona A.

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference24 articles.

1. Lenalidomide, bortezomib, and dexamethasone with transplantation for myeloma;Attal;N Engl J Med,2017

2. Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial;Goldschmidt;Leukemia,2018

3. Long-term follow-up results of lenalidomide, bortezomib, and dexamethasone induction therapy and risk-adapted maintenance approach in newly diagnosed multiple myeloma;Joseph;J Clin Oncol,2020

4. Current status of autologous stem cell transplantation for multiple myeloma;Al Hamed;Blood Cancer J,2019

5. KRD-PACE mobilization for multiple myeloma patients with significant residual disease before autologous stem-cell transplantation;Cowan;Clin Lymphoma Myeloma Leuk,2020

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive model of the efficiency of hematopoietic stem cell collection in patients with multiple myeloma and lymphoma based on multiple peripheral blood markers;International Journal of Laboratory Hematology;2024-07-03

2. Effect of prior lenalidomide or daratumumab exposure on hematopoietic stem cell collection and reconstitution in multiple myeloma;Annals of Hematology;2024-03-06

3. Сравнительный анализ эффективности режимов мобилизации аутологичных гемопоэтических стволовых клеток у больных множественной миеломой;Clinical Oncohematology;2024-02-20

4. Stem cell collection after lenalidomide, bortezomib and dexamethasone plus elotuzumab or isatuximab in newly diagnosed multiple myeloma patients: a single centre experience from the GMMG-HD6 and -HD7 trials;BMC Cancer;2023-11-21

5. Impact of Clinical Parameters and Induction Regimens on Peripheral Blood Stem-Cell Mobilization and Collection in Multiple Myeloma Patients;Transfusion Medicine and Hemotherapy;2023